Controversy around nevirapine trials continues.

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	74
Number of pages	1
Journal	The Lancet Infectious Diseases
Volume	5
Issue number	2
DOIs	https://doi.org/10.1016/s1473-3099(05)01266-1
Publication status	Published - Feb 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{beb0f7b510b04ab285d1394d0b1b38c8,

title = "Controversy around nevirapine trials continues.",

author = "Khabir Ahmad",

year = "2005",

month = feb,

doi = "10.1016/s1473-3099(05)01266-1",

language = "English (US)",

volume = "5",

pages = "74",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "2",

}

TY - JOUR

T1 - Controversy around nevirapine trials continues.

AU - Ahmad, Khabir

PY - 2005/2

Y1 - 2005/2

UR - https://www.scopus.com/pages/publications/15044359046

U2 - 10.1016/s1473-3099(05)01266-1

DO - 10.1016/s1473-3099(05)01266-1

M3 - Article

C2 - 15702502

AN - SCOPUS:15044359046

SN - 1473-3099

VL - 5

SP - 74

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 2

ER -